rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

iSpecimen Inc.

ISPC · Nasdaq

Health CareLife-science toolsNot moving yet

ISPC stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 70.4% below that average now. Life Science Tools & Research Services: 58% of its 79 stocks in an uptrend (+6 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
58% +6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
7 (-5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

22 Apr – 21 Oct
26%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders7-5 on the quarter
New · exited1 · 6
Reported value$150K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGreduced · filed 13 Aug 202632,037$85K-21,707−40.4%
JANE STREET GROUP, LLCreduced · filed 14 Aug 202624,414$65K-31,217−56.1%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026219$580-6,432−96.7%
BlackRock, Inc.reduced · filed 7 Aug 202671$188-2,756−97.5%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202631$82-1,206−97.5%
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 20262$5+2
SBI Securities Co., Ltd.reduced · filed 23 Jul 20261$3-18−94.7%
31 Mar 2023 – 30 Jun 2026
5913Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Avtar Dhaliwal Company insiderDirector · last 25 Sep 20240 · 0
Katharyn Field Company insiderDirector · last 25 Sep 20240 · 0
Richard Paolone Company insiderDirector · last 25 Sep 20240 · 0
Elizabeth Ames Graham Company insiderDirector · last 21 Mar 20240 · 0
Andrew L. Ross Company insiderDirector · last 2 Jan 20246 · 0
John L. Brooks III Company insiderDirector · last 2 Jan 20240 · 0
Steven R. Ph.d. Gullans Company insiderDirector · last 2 Jan 20240 · 0
Theresa L. Mock Company insiderDirector · last 2 Jan 20240 · 0
Benjamin Bielak Company insiderChief Info Officer & Secretary · last 14 Sep 20231 · 0
Tracy Curley Company insiderCEO, CFO and Treasurer · last 31 May 20233 · 0
Jill Mullan Company insiderDirector · last 17 Jan 20230 · 0
Christopher Ianelli Company insiderDirector · last 6 Jan 20230 · 0

Same industry

OABI OmniAbLeading+72%
TXG 10x GenomicsLeading+69%
ILMN IlluminaLeading+53%
AVTR AvantorLeading+52%
RVTY RevvityLeading+39%
ABSI AbsciLeading+36%
MASS 908 DevicesLeading+35%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202511.2%
Operating profit marginFY 2025 · to 31 Dec 2025-465%
Free cash flow marginFY 2025 · to 31 Dec 2025-220%
Share count trendFY 2025 · to 1 Apr 2026250%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.9M
Free cash flowFY 2025 · to 31 Dec 2025−$4.2M

Analyst forecasts

No analyst forecasts yet.